5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Suraksha Diagnostic Ltd.

•
surakshanet.comBSE: 544293NSE: SURAKSHA
Market Cap₹ 1,688 Cr.
Current Price
High / Low₹ 349 / 224
Stock P/E47.1
Book Value₹ 49
Price to Book4.87
Dividend Yield0.15 %
ROCE25.0 %
ROE13.8 %
Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 37.3% CAGR over last 5 years
  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 24.3%
  • Latest quarter profit grew 40.0% YoY, showing strong momentum
  • Company has consistently been profitable over the last 5 years
  • Operating margins have improved to 31.0% from 25.2%

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Promoter holding has decreased over last 2 years: -13.9pp
  • Equity base is being diluted - shares outstanding up 51.0%
  • Though reporting repeated profits, the company pays out little dividend (8.1%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.APOLLOHOSP8850.0060.90127249.420.23610.4038.417043.5020.5621.7315.70
2.MAXHEALTH1037.2069.29100951.740.19322.964.872366.1716.7014.9725.29
3.MANIPALHOS716.15105.5794200.740.002434.30—30906.30—13.9323.83
4.FORTIS887.3063.9366987.440.11272.802.262545.0317.4614.0721.28
5.ASTERDM762.95208.6966504.250.3929.28-68.701310.6821.6011.2619.53
6.MEDANTA1447.5569.9838920.530.03157.25-1.091304.0526.5019.3821.99
7.NH1867.3546.7638161.310.24207.275.372683.6378.0516.2017.43
8.KIMS768.85158.0632292.200.0037.40-56.001179.5035.3311.5119.03
9.LALPATHLAB1909.4059.1432049.051.071705.001172.397977.001090.9529.5631.03
10.AGARWALEYE507.00108.3316073.230.00550.201345.616140.201159.7316.1427.75
11.VIJAYA1502.3082.5315473.350.1353.1037.61230.9822.8330.2842.66
12.SURAKSHA324.0547.151687.680.1512.8440.0087.6520.7424.9734.73
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
605255616760657379788188
393736404441464955555772
Operating Profit211519212318192424232415
OPM %34.70%29.54%35.28%33.92%34.74%30.67%29.48%32.72%30.62%29.81%29.93%17.61%
110111111111
Interest222222233344
Depreciation8889999910111111
Profit before Tax11691114891212101017
Tax %23.97%27.01%31.53%27.12%25.53%25.59%22.15%26.38%26.72%28.03%38.28%22.27%
Net Profit00001067997613
1.580.871.221.491.941.181.421.801.731.441.212.50

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015Mar 2016Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
7099157140223190219252310325
5377123117175146148170214238
Operating Profit17223423484471829687
OPM %24.80%22.24%21.65%16.15%21.54%23.37%32.41%32.50%30.98%26.75%
1121243433
Interest14222101091314
Depreciation691316153233354143
Profit before Tax121021633731414549
Tax %34.69%45.05%27.61%-0.96%28.45%10.12%26.47%25.18%29.52%27.85%
Net Profit8515624623313135
EPS0.000.00178.0075.00278.471.22342.406.116.18—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%8.09%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
17%
3 Years:
18%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
38%
3 Years:
70%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
4%

RETURN ON EQUITY

10 Years:
—
5 Years:
13%
3 Years:
15%
Last Year:
14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Sep 15

₹ 0.25

Rs.0.5000 per share(25%)Final Dividend

2026

Aug 25

₹ 0.25

Rs.0.5000 per share(25%)Final Dividend

Mar 2015Mar 2016Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
77777771010
Minority Interest00000-0-0-1-1
4147111118141147171201233
233381619867574136
Trade Payables131013131414141421
202934171927333649
Total Liabilities104125173171201281300334448
7391128119119195212223315
Capital Work in Progress00001211035
005500010
245466788
00000091423
Cash & Bank12944355552026
162130387122175841
Total Assets104125173171201281300334448

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015Mar 2016Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
221638254751606382
Cash from Investing-42-26-20-28-44-21-35-40-52
Cash from Financing1710-1031-24-25-24-29
-6-31-1-0-10-01

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015Mar 2016Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Mar 2022Mar 2023Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
62.9662.9648.7848.7848.8848.9849.0049.1049.10
0.000.0015.3914.4613.9513.7313.4613.4613.47
0.000.0020.4322.0522.3721.9822.5723.1423.22
Government0.000.000.000.000.000.000.000.000.00
37.0437.0415.3914.7014.8015.3114.9814.3114.21

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-31
Copy of Newspaper Publication

2026-08-31 - Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication published today, i.e. on Monday, 31 August, 2026 with respect to the Notice of the 21st Annual General Meeting of the Company scheduled to be held on Tuesday, 22 September, 2026 and e-voting information.

2026-08-27
General Updates

2026-08-27 - Pursuant to Regulation 36(1)(b) of the SEBI Listing Regulations, a letter to those Members whose e-mail addresses are not registered with the Company/Registrar and Share Transfer Agent (RTA), i.e. KFin Technologies Limited/Depository Participants (DPs)/Depositories is being dispatched by the Company.

2026-08-27
Shareholders meeting

2026-08-27 - Notice of 21st Annual General Meeting to be held on September 22, 2026.

2026-08-25
Copy of Newspaper Publication

2026-08-25 - Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-25
Copy of Newspaper Publication

2026-08-25 - Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-17
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-17 - Suraksha Diagnostic Limited has informed the Exchange about Transcript

2026-08-17
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-17 - Suraksha Diagnostic Limited has informed the Exchange about Transcript

2026-08-13
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-13 - Suraksha Diagnostic Limited has informed the Exchange about Link of Recording

2026-08-13
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-13 - Suraksha Diagnostic Limited has informed the Exchange about Link of Recording

News

Recent coverage and analyst commentary for SURAKSHA

Loading news…

🤖

AI Stock Analyst

Suraksha Diagnostic Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login